TPL-2 Regulates Macrophage Lipid Metabolism and M2 Differentiation to Control TH2-Mediated Immunopathology
Yashaswini Kannan(The Francis Crick Institute), Mark S. Wilson(Gene Therapy Laboratory), Luiz Pedro S. de Carvalho(The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology), Lewis J. Entwistle(The Francis Crick Institute), Steven C. Ley(University College London), Yanda Li(Chinese Academy of Sciences), Stanley Ching‐Cheng Huang(Washington University in St. Louis), Nuha R. Mansour(London School of Hygiene & Tropical Medicine), Jimena Perez-Lloret(The Francis Crick Institute), Radma Mahmood(The Francis Crick Institute), Stamatia Papoutsopoulou(University of Thessaly), Edward J. Pearce(Bloomberg (United States)), Hania Khoury(The Francis Crick Institute)
Cited by 23
Related Papers
Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
|Cell Metabolism|2016|1.5k
Toll-like receptor–induced changes in glycolytic metabolism regulate dendritic cell activation
|Blood|2010|1.2k
Type 2 immunity in tissue repair and fibrosis
|Nature reviews. Immunology|2017|1.1k
TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation
|Nature Immunology|2014|1k
Pulmonary fibrosis: pathogenesis, etiology and regulation
|Mucosal Immunology|2009|834